Fidelity Investments
VAXX

Fidelity Investments’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Fidelity Investments’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,422
Closed -$6.04K – 5729
2024
Q1 		$6.04K Buy
8,422
+5,622
+201% +$4.08K ﹤0.01% 4450
2023
Q4 		$2.38K Buy
2,800
+1,728
+161% +$1.67K ﹤0.01% 4608
2023
Q3 		$1.47K Buy
1,072
+818
+322% +$1.77K ﹤0.01% 4594
2023
Q2 		$640 Buy
+254
New +$538 ﹤0.01% 4775

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Fidelity Investments's VAXX Position: Q2 2024 in Review

Fidelity Investments sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 8,422 shares — an estimated $6.04K sold.

Fidelity Investments first reported a position in VAXX in Q2 2023 and held it in 4 quarters. The position peaked at $6.04K in Q1 2024. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Fidelity Investments reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Fidelity Investments sold 8,422 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $6.04K.
  • Fidelity Investments first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2023 and held it in 4 quarters.
  • Fidelity Investments's Vaxxinity, Inc. Class A Common Stock position peaked at $6.04K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.